This topic contains a solution. Click here to go to the answer

Author Question: Young female athletes often experience a delay in menarche of approximately what duration? a. 6 ... (Read 69 times)

123654777

  • Hero Member
  • *****
  • Posts: 585
Young female athletes often experience a delay in menarche of approximately what duration?
 a. 6 months to 1 year
 b. 1 to 2 years
 c. 2 to 4 years
 d. 5 years
 e. They do not experience a delay in menarche.

Question 2

Which snack food exerts the most favorable effect on blood lipid levels?
 
 a. pretzels
  b. cheese and crackers
  c. walnuts and almonds
  d. microwave popcorn



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Hikerman221

  • Sr. Member
  • ****
  • Posts: 346
Answer to Question 1

c

Answer to Question 2

c




123654777

  • Member
  • Posts: 585
Reply 2 on: Aug 20, 2018
Thanks for the timely response, appreciate it


carlsona147

  • Member
  • Posts: 341
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

Side effects from substance abuse include nausea, dehydration, reduced productivitiy, and dependence. Though these effects usually worsen over time, the constant need for the substance often overcomes rational thinking.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

Of the estimated 2 million heroin users in the United States, 600,000–800,000 are considered hardcore addicts. Heroin addiction is considered to be one of the hardest addictions to recover from.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library